Home/Cleara Biotech/Marianne Mertens
MM

Marianne Mertens

Board Member

Cleara Biotech

Therapeutic Areas

Cleara Biotech Pipeline

DrugIndicationPhase
CL04177Metastatic Colorectal Cancer (mCRC), Triple-Negative Breast Cancer (TNBC), solid tumors, hematological malignanciesPre-clinical
CL04183Metastatic Colorectal Cancer (mCRC), Triple-Negative Breast Cancer (TNBC), solid tumors, hematological malignanciesPre-clinical
FOXO4/p53 Peptide PlatformVarious cancers and chronic diseases driven by specific senescence subtypesDiscovery/Pre-clinical